The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

Introduction: An international database was collected to inform the 8th edition of the anatomic classification of lung cancer. The present analyses concern its primary tumor (T) component. Methods: From 1999 to 2010, 77,156 evaluable patients, 70,967 with non–small-cell lung cancer, were collected; and 33,115 had either a clinical or a pathological classification, known tumor size, sufficient T information, and no metastases. Survival was measured from date of diagnosis or surgery for clinically and pathologically staged tumors. Tumor-size cutpoints were evaluated by the running log-rank statistics. T descriptors were evaluated in a multivariate Cox regression analysis adjusted for age, gender, histological type, and geographic region. Results: The 3-cm cutpoint significantly separates T1 from T2. From 1 to 5 cm, each centimeter separates tumors of significantly different prognosis. Prognosis of tumors greater than 5 cm but less than or equal to 7 cm is equivalent to T3, and that of those greater than 7 cm to T4. Bronchial involvement less than 2 cm from carina, but without involving it, and total atelectasis/pneumonitis have a T2 prognosis. Involvement of the diaphragm has a T4 prognosis. Invasion of the mediastinal pleura is a descriptor seldom used. Conclusions: Recommended changes are as follows: to subclassify T1 into T1a (⩽1 cm), T1b (>1 to ⩽2 cm), and T1c (>2 to ⩽3 cm); to subclassify T2 into T2a (>3 to ⩽4 cm) and T2b (>4 to ⩽5 cm); to reclassify tumors greater than 5 to less than or equal to 7 cm as T3; to reclassify tumors greater than 7 cm as T4; to group involvement of main bronchus as T2 regardless of distance from carina; to group partial and total atelectasis/pneumonitis as T2; to reclassify diaphragm invasion as T4; and to delete mediastinal pleura invasion as a T descriptor.

[1]  Bronchogenic Clinical tumour size and prognosis in lung cancer. Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S). , 1999, The European respiratory journal.

[2]  Kenji Suzuki,et al.  The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  J. Pignon,et al.  Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Miyaoka,et al.  How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. , 2006, The Journal of thoracic and cardiovascular surgery.

[6]  D. Ornstein TNM Supplement: A Commentary on Uniform Use 2nd ed. , 2002 .

[7]  H. Libshitz,et al.  Patterns of mediastinal metastases in bronchogenic carcinoma. , 1986, Chest.

[8]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Data Elements for the Prospective Project , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  J. V. van Meerbeeck,et al.  Determination of the molecular relationship between multiple tumors within one patient is of clinical importance. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  V. Rusch,et al.  Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. , 2003, The Journal of thoracic and cardiovascular surgery.

[11]  R. Rami-Porta,et al.  Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1,020 patients. , 2002, Chest.

[12]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[13]  F. Petrella,et al.  Outcome and prognostic factors of resected non-small-cell lung cancer invading the diaphragm. , 2013, Interactive cardiovascular and thoracic surgery.

[14]  J. Furák,et al.  Lung cancer and its operable brain metastasis: survival rate and staging problems. , 2005, The Annals of thoracic surgery.

[15]  D. Miller,et al.  Results of surgical resection in patients with N2 non-small cell lung cancer. , 1994, The Annals of thoracic surgery.

[16]  N. Tsubota,et al.  Skip metastasis and hidden N2 disease in lung cancer: How successful is mediastinal dissection? , 1996, Surgery Today.

[17]  E. Miyaoka,et al.  Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale Nation-Wide Database , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[18]  K. Athanassiadi,et al.  Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  John Crowley,et al.  Some Exploratory Tools for Survival Analysis , 1997 .

[20]  M. Okada,et al.  Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinomas: role of subcarinal nodes in selective dissection. , 1998, The Journal of thoracic and cardiovascular surgery.

[21]  A. Sakurada,et al.  Five‐year survivors with resected PN2 nonsmall cell lung carcinoma , 1999, Cancer.

[22]  J. Verschakelen,et al.  Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer , 2007, European Respiratory Journal.

[23]  H. D. de Koning,et al.  Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. , 2013, American journal of respiratory and critical care medicine.

[24]  R. Tsuchiya,et al.  Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. , 2001, The Annals of thoracic surgery.

[25]  M. Riquet,et al.  Surgical management of non-small cell lung cancer with synchronous brain metastases. , 2001, Chest.

[26]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[27]  C. Sima,et al.  Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma. , 2013, Chest.

[28]  X. Bonfill,et al.  Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. , 2006, The Cochrane database of systematic reviews.

[29]  T. Naruke,et al.  Lymph node mapping and curability at various levels of metastasis in resected lung cancer. , 1978, The Journal of thoracic and cardiovascular surgery.

[30]  Y. Ichinose,et al.  Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer. , 1996, The Annals of thoracic surgery.

[31]  J. Lammers,et al.  p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma , 2002, Cancer.

[32]  M. Haniuda,et al.  [Assessment of the new TNM classification for resected lung cancer]. , 2000, Kyobu geka. The Japanese journal of thoracic surgery.

[33]  H. Groen,et al.  Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  C. Mountain,et al.  Revisions in the International System for Staging Lung Cancer. , 1997, Chest.

[35]  K. Yasumoto,et al.  Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. , 1999, Chest.

[36]  Bonny R. Hart,et al.  Prognostic significance of N1 disease in carcinoma of the lung. , 1983, The Journal of thoracic and cardiovascular surgery.

[37]  J. Crowley,et al.  Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer? , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[38]  C. Gutschow,et al.  Role of skip metastasis to mediastinal lymph nodes in non‐small cell lung cancer , 2003, Journal of surgical oncology.

[39]  A. Perruchoud,et al.  Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning. , 1991, Thorax.

[40]  T. de Giacomo,et al.  Prognostic factors after surgical treatment of lung cancer invading the diaphragm. , 1999, The Annals of thoracic surgery.

[41]  H. Asamura,et al.  Where is the boundary between N1 and N2 stations in lung cancer? , 2000, The Annals of thoracic surgery.

[42]  S. Yamazaki,et al.  [Validity and controversies in the new postoperative pathologic TNM classification based on the results of surgical treatment of non-small cell lung cancer]. , 2000, Kyobu geka. The Japanese journal of thoracic surgery.

[43]  P. Goldstraw The International Staging Committee of the IASLC: Its origins and purpose , 2002 .

[44]  H. Li,et al.  Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.

[45]  D. Skinner,et al.  The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer , 1986 .

[46]  A. Dujon,et al.  Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. , 1999, The Annals of thoracic surgery.

[47]  G. Bepler,et al.  Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[49]  J. Vansteenkiste,et al.  Practical approach to patients presenting with multiple synchronous suspect lung lesions: a reflection on the current TNM classification based on 54 cases with complete follow-up. , 2001, Lung cancer.

[50]  G. Darling,et al.  Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set. , 2012, Lung cancer.

[51]  A. Marrogi,et al.  Lung cancer staging: a case for a new T definition. , 2006, The Annals of thoracic surgery.

[52]  A. Marra,et al.  Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis. , 2003, The Journal of thoracic and cardiovascular surgery.

[53]  M. Tsuboi,et al.  Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. , 2001, The Journal of thoracic and cardiovascular surgery.

[54]  J. Lammers,et al.  Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma. , 1999, The Annals of thoracic surgery.

[55]  Y. Ohno,et al.  Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. , 2004, The Journal of thoracic and cardiovascular surgery.

[56]  K. Nackaerts,et al.  Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases , 1997 .

[57]  E. Miyaoka,et al.  Visceral Pleural Invasion Classification in Non–Small-Cell Lung Cancer in the 7th Edition of the Tumor, Node, Metastasis Classification for Lung Cancer: Validation Analysis Based on a Large-Scale Nationwide Database , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[58]  P. Goldstraw Report on the international workshop on intrathoracic staging. London, October 1996 , 1997 .

[59]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[60]  P. Hudgins,et al.  Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. , 1991, AJNR. American journal of neuroradiology.

[61]  K. Nagai,et al.  Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. , 2011, Chest.

[62]  I sabel Mortara,et al.  International Union against Cancer , 1938, Nature.

[63]  T. Araki,et al.  Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.

[64]  R. Snijder,et al.  Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases. , 1996, Chest.

[65]  M. Riquet,et al.  Results of surgical treatment of lung cancer involving the diaphragm. , 2001, The Journal of thoracic and cardiovascular surgery.

[66]  Kenji Suzuki,et al.  Intrapulmonary metastasis of non-small cell lung cancer: a prognostic assessment. , 2001, The Journal of thoracic and cardiovascular surgery.

[67]  N. Martini Mediastinal lymph node dissection for lung cancer. The Memorial experience. , 1995, Chest surgery clinics of North America.

[68]  Robert D Timmerman,et al.  Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. , 2006, Seminars in radiation oncology.

[69]  M. Terashima,et al.  Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. , 1997, The Journal of thoracic and cardiovascular surgery.

[70]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[71]  E. Miyaoka,et al.  T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer. , 2001, The Journal of thoracic and cardiovascular surgery.

[72]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[73]  J. Crowley,et al.  The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer , 2006 .

[74]  Akihiko Yoshizawa,et al.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.

[75]  V. Calvo,et al.  Resección de carcinoma broncogénico con invasión diafragmática , 1999 .

[76]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[77]  J. Padilla,et al.  Surgical results and prognostic factors in early non-small cell lung cancer. , 1997, The Annals of thoracic surgery.

[78]  M. Okada,et al.  Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study. , 2012, The Journal of thoracic and cardiovascular surgery.

[79]  E. Rosenow,et al.  Evaluation and management of solitary and multiple pulmonary nodules. , 1992, Clinics in chest medicine.

[80]  R. Tsuchiya,et al.  Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis. , 1999, The Journal of thoracic and cardiovascular surgery.

[81]  H. Dienemann,et al.  Adrenalectomy for solitary adrenal metastases from non-small cell lung cancer. , 2005, Lung cancer.

[82]  Tao-Sheng Li,et al.  Independent predictive value of the overall number of metastatic N1 and N2 stations in lung cancer. , 2003, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[83]  P. Goldstraw Staging manual in thoracic oncology , 2009 .

[84]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.

[85]  J. Padilla,et al.  [Resection of bronchogenic carcinoma invading the diaphragm]. , 1999, Archivos de bronconeumologia.

[86]  E. Ruffini,et al.  Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases. , 1990, International surgery.

[87]  G. Watanabe,et al.  Results of initial operations in non-small cell lung cancer patients with single-level N2 disease. , 2006, The Annals of thoracic surgery.

[88]  M. Vangel,et al.  Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. , 2004, The Journal of thoracic and cardiovascular surgery.

[89]  D. Boffa,et al.  Reacting to Changes in Staging Designations in the 7th Edition of the AJCC Staging Manual , 2010, Annals of Surgical Oncology.

[90]  S. Takeda,et al.  Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. , 2005, The Annals of thoracic surgery.

[91]  P. Goldstraw,et al.  Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease). , 1994, The Journal of thoracic and cardiovascular surgery.

[92]  H. Horinouchi,et al.  [Surgical indications for lung cancer: influence of the M factor]. , 2001, Nihon Geka Gakkai zasshi.

[93]  M. Okada,et al.  Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival? , 1999, The Journal of thoracic and cardiovascular surgery.

[94]  R. Rami-Porta,et al.  Strength and weakness of the new TNM classification for lung cancer , 2010, European Respiratory Journal.

[95]  Y. Ichinose,et al.  Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. , 1994, The Journal of thoracic and cardiovascular surgery.

[96]  R. Rami-Porta,et al.  Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the Staging Project Database of the International Association for the Study of Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[97]  V. Rusch,et al.  Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[98]  V. Rusch,et al.  Survival after resection of stage II non-small cell lung cancer. , 1992, The Annals of thoracic surgery.

[99]  A. Dujon,et al.  Factors determining survival in resected N2 lung cancer. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[100]  J. Usuda,et al.  Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer. , 2012, Lung cancer.

[101]  R. Snijder,et al.  Lymph node type as a prognostic factor for survival in T2 N1 M0 non-small cell lung carcinoma. , 1997, The Annals of thoracic surgery.

[102]  P. Zanen,et al.  Survival in synchronous vs. single lung cancer: upstaging better reflects prognosis. , 2000, Chest.